Sentences with phrase «placebo daily»

A 2016 study in the American Journal of Clinical Nutrition gave zinc - deficient nursing home residents a zinc supplement or a placebo daily.

A total of 60 men between 25 and 60 years of age took either 600 mg of fenugreek or a placebo daily over the course of 6 weeks (14).

The two groups of men were given two different pills — one was given a placebo daily for a year and the other one was taking 3332 IUs of vitamin D.

For an eight - week period, participants received gabapentin (900 mg) daily, gabapentin placebo daily, electroacupuncture (twice per week for two weeks, then once weekly), or «sham» electroacupuncture, which involves no actual needle penetration or electrical current.

Participants were randomized to receive either 130 milligrams of evacetrapib or a placebo daily for at least 18 months.

In this study, 1200 HIV - negative, sexually active people from Botswana received either Truvada or a placebo daily.

The enrolled children were randomly assigned to either receive 1.3 grams of omega - 3 fatty acids or an identical placebo daily for six weeks.

The initiation stratum continued 100 mg aspirin or placebo daily for 30 days.

But in a more rigorous study — which randomly assigned participants to take either NSAIDs or a placebo daily for several years and administered annual cognitive tests — anti-inflammatories did not seem to help.

Not exact matches

It may have to do with Addyi's high pricing (on par with Viagra at $ 26 per pill without an assistance program), its daily intake requirement (unlike Viagra, it adds up to $ 780 per month), its potentially deleterious side effects (low blood pressure and fainting), its restrictions on alcohol consumption (abstinence vs. large quantities not recommended for Viagra patients), a 10 % efficacy rate (whereas Viagra works 50 % of the time compared to a placebo, according to a recent study), and its subtle neurotransmitter - targeting mechanism (contrast that to the obvious hydraulics of Viagra).

A study in the New England Journal of Medicine stated that daily doses of cayenne pepper reduced the symptoms of indigestion in a placebo - controlled trial.

Results: Daily ingestion of wheat - based starch hydrolysates, glucose syrups and maltodextrins, had no deleterious effect on small - bowel mucosal villous architecture or inflammation in coeliac disease patients when compared to the placebo group.

Half of the participants took one gram of curcumin powder daily for eight weeks while the other half received a placebo pill.

The fish oil group took omega - 3 fatty acids daily as did the placebo (olive oil) group.

The New England Journal of Medicine study included 346 pregnant women in their 3d trimester who took omega - 3 fatty acids daily and 349 who took a placebo.

For 8 weeks, they fed normal mice a high - fat diet and gave them daily injections of either TNP, a well - known IP6K1 inhibitor, or a placebo.

In addition, they were randomly assigned, in a 2 - to - 1 ratio, to a once - daily injection with either 3 mg of liraglutide (2,487 subjects) or placebo (1,244 subjects) for 56 weeks.

One group received twice - daily oral doses of creatine, up to a maximum of 30 grams per day, the other received placebo.

In addition, they were randomly assigned, in a 2 - to - 1 ratio, to a once - daily injection with either 3 mg of liraglutide or placebo for 56 weeks.

Both placebo and supplements were given once monthly — rather than daily at home — at the GPI to ensure consistent compliance.

Patients in the study received dupilumab or placebo added to their regular, twice daily dose of fluticasone / salmeterol.

Trial participants were divided into three groups: daily white and twice monthly yellow placebo, daily 800 IU vitamin D3 (low dose) and twice monthly yellow placebo, and daily white placebo and twice monthly 50,000 IU vitamin D3 (high dose).

daily of simvastatin, a common statin drug used to prevent heart attack and stroke, and 447 took a daily placebo, or dummy pill.

Ezio Bonifacio, Ph.D., of the DFG Center for Regenerative Therapies Dresden, Technische Universitat Dresden, Germany and colleagues randomly assigned autoantibody - negative, genetically at - risk children to receive oral insulin at varying doses (n = 15) or placebo (n = 10) once daily for 3 to 18 months to assess whether oral insulin can induce a potentially protective immune response without causing adverse effects.

The group that took the daily omega fatty acid supplement exhibited a greater reduction in ASD symptoms than those who took the placebo, according to ratings provided by the children's parents.

In a pilot study that included children at high risk for type 1 diabetes, daily high - dose oral insulin, compared with placebo, resulted in an immune response to insulin without hypoglycemia, findings that support the need for a phase 3 trial to determine whether oral insulin can prevent islet autoimmunity and diabetes in high - risk children, according to a study in the April 21 issue of JAMA, a theme issue on child health.

Half were given a placebo for six weeks, then took a 500 mg twice - daily dose of nicotinamide riboside (NR) chloride (NIAGEN).

For 3 months, half of them took a daily dietary supplement that contained a special combination of omega - 3 and omega - 6 fatty acids, and the other half took a placebo, although families were unaware of which they received to make the study rigorous.

In a pilot study involving 13 patients with non-cardiac chest pain, Dr. Schey and his research team found that patients who were given 5 mg of dronabinol twice daily for four weeks fared better than patients who took a placebo, or dummy pill.

In the new study, researchers led by Yehezkel Ben - Ari at the Mediterranean Institute of Neurobiology in Marseille, France, recruited 60 autistic children between the ages of 3 and 11 and randomly assigned them to receive either a daily pill of bumetanide or a placebo.

Participants in the trial who were experiencing their first demyelinating symptoms were randomized to receive 100 mg twice daily of the oral minocycline or placebo.

The women were randomly assigned to either take a resveratrol supplement or a placebo pill daily for three months.

This study was a randomized, double - blind, placebo - controlled trial designed to characterize the safety, tolerability and pharmacokinetics of AVI - 7288 after daily repeat dosing.

Some trial participants were randomly assigned to use inhalers daily while some used them intermittently; some received placebos and some received no treatment.

Gregory D. Lewis, M.D., of Massachusetts General Hospital, Boston, and colleagues randomly assigned 225 patients with HFrEF and iron deficiency to receive oral iron polysaccharide (n = 111) or placebo (n = 114), 150 mg twice daily for 16 weeks.

In one study, half of 635 patients with a history of colon or rectal cancer took one aspirin daily while the rest took a placebo.

Participants with symptomatic heart failure and a left ventricular ejection fraction of 45 percent or more (normal or near normal contractions) were randomized to receive either spironolactone (15 to 45 milligrams daily) or matching placebo, and were followed for an average of nearly 3.3 years.

Starting in 2008, Marzia Lazzerini of the Institute for Maternal and Child Health in Trieste, Italy, and her colleagues randomly assigned 54 children with Crohn's to get daily thalidomide or a placebo.

Paul D. Miller, M.D., of the Colorado Center for Bone Research, Lakewood, Colo., and colleagues randomly assigned postmenopausal women with osteoporosis to receive daily injections for 18 months of placebo (n = 821); abaloparatide (n = 824); or teriparatide (n = 818).

Among postmenopausal women with osteoporosis at risk of fracture, daily injection of the drug abaloparatide for 18 months significantly reduced the risk of new vertebral and nonvertebral fractures compared with placebo, according to a study appearing in the August 16 issue of JAMA.

Subjects took the drug or placebo for 28 days once daily with food.

Findings from the MS - STAT trial showed that a high, daily dose of simvastatin was safe, well tolerated, and slowed brain atrophy (shrinkage) by 43 % over two years compared with placebo.

According to the trial's crossover design, patients with refractory chronic cough of at least eight weeks» duration were randomly assigned initially to either AF - 219 or placebo treatment twice daily for two weeks, followed by a washout period, and further followed by crossover to the alternative treatment arm (AF - 219 or placebo) for an additional two weeks.

But a trial in which Kenyan women received a tenofovir pill daily was halted earlier this year after recipients seemed to be no better protected than those on placebos.

In the present study carried out at the University of Eastern Finland, Kuopio, the study participants were given a daily dose of either 40 or 80 micrograms of vitamin D, or a placebo, over a course of 5 months during Finnish winter..

The Physicians» Health Study II (PHS II) remains the only randomized, large - scale, long - term trial to test whether a daily multivitamin reduced cardiovascular disease risk, and researchers found that after 11 years of follow up, there was no significant difference in risk of major cardiovascular disease (CVD) events among men who took a multivitamin compared to those that took a placebo.

Half of the children took a daily Omega - 3 fish oil supplement and the remaining children took a placebo for 16 weeks.

The patients, from 1,144 sites in 31 countries, were randomly assigned to a twice - daily regimen of ticagrelor at 90 mg, ticagrelor at 60 mg or placebo.

Patients were assigned to cohorts by BRCA mutation status and randomised 2:1 to receive niraparib 300 mg or placebo once daily.

Researchers enrolled 573 patients with intermediate or advanced stage hepatocellular carcinoma, who had all been previously treated with sorafenib, and randomized them 2:1 to 160 mg oral regorafenib or placebo once daily for 1 - 3 of each four week cycle, in addition to best supportive care.